[ad_1]
NBC News: “Antibody tests need to be in place for 2nd coronavirus wave, CDC director says,” April 13, 2020.
Yvonne Maldonado, MD, senior associate dean for faculty development and diversity, professor of pediatrics — infectious diseases, and of health research and policy, Stanford University.
Aneesh Mehta, MD, associate professor, division of infectious diseases, Emory University School of Medicine.
National Institutes of Health: “NIH begins study to quantify undetected cases of coronavirus infection,” April 10, 2020.
ClinicalTrials.gov: “SARS-COV2 Pandemic Serosurvey and Blood Sampling,” identifier NCT04334954.
Co-Immunity Project.
News release, FDA, April 15, 2020.
FDA: “Cellex qSARS-CoV-2 IgG/IgM Rapid Test.”
Abbott: “Abbott Launches Third COVID-19 Test, a Laboratory-Based Antibody Blood Test That Will Ship in the U.S. Starting Tomorrow,” April 15, 2020.
CIDRAP News: “Antibody tests may hold clues to COVID-19 exposure, immunity — but it’s complicated,” April 15, 2020.
“COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University.”
Michael Mina, MD, PhD, assistant professor of epidemiology, Harvard T.H. Chan School of Public Health.
Matthew Sims, MD, PhD, director of infectious disease research, Beaumont Health.
The Boston Globe: “Harvard president and wife, both recovered from coronavirus, boost scientists’ effort with blood donations,” April 14, 2020.
Abbott.
Marc Lipsitch, PhD, professor of epidemiology, Harvard T.H. Chan School of Public Health.
